Back to Search
Start Over
Animal model studies yield translational solutions for cochlear drug delivery.
- Source :
-
Hearing research [Hear Res] 2018 Oct; Vol. 368, pp. 67-74. Date of Electronic Publication: 2018 May 05. - Publication Year :
- 2018
-
Abstract
- The field of hearing and deafness research is about to enter an era where new cochlear drug delivery methodologies will become more innovative and plentiful. The present report provides a representative review of previous studies where efficacious results have been obtained with animal models, primarily rodents, for protection against acute hearing loss such as acoustic trauma due to noise overexposure, antibiotic use and cancer chemotherapies. These approaches were initiated using systemic injections or oral administrations of otoprotectants. Now, exciting new options for local drug delivery, which opens up the possibilities for utilization of novel otoprotective drugs or compounds that might not be suitable for systemic use, or might interfere with the efficacious actions of chemotherapeutic agents or antibiotics, are being developed. These include interesting use of nanoparticles (with or without magnetic field supplementation), hydrogels, cochlear micropumps, and new transtympanic injectable compounds, sometimes in combination with cochlear implants.<br /> (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Cochlea pathology
Cochlea physiopathology
Hearing Loss pathology
Hearing Loss physiopathology
Labyrinth Diseases pathology
Labyrinth Diseases physiopathology
Models, Animal
Cochlea drug effects
Drug Delivery Systems
Hearing drug effects
Hearing Loss drug therapy
Labyrinth Diseases drug therapy
Pharmaceutical Preparations administration & dosage
Translational Research, Biomedical methods
Subjects
Details
- Language :
- English
- ISSN :
- 1878-5891
- Volume :
- 368
- Database :
- MEDLINE
- Journal :
- Hearing research
- Publication Type :
- Academic Journal
- Accession number :
- 29793764
- Full Text :
- https://doi.org/10.1016/j.heares.2018.05.002